Skip to main content
Premium Trial:

Request an Annual Quote

But Maybe Not So Useful

At MIT's Tech Review, Emily Singer discusses new genetic tests launched by Decode this week. One looks for variations linked to various cardiovascular diseases and the other for variations associated with cancer risk and they are priced at $195 and $225. However, the clinical utility of tests that include multiple genetic risk factors hasn't yet been worked out. "We don't yet know how to combine such data in an accurate way," UNC-Chapel Hill's James Evans says.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.